Search Editorial Photos
"shared use path"
65 professional editorial images found
#11901373
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901374
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901375
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901376
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901377
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901378
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901379
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11901380
29 December 2024
In Passau, Lower Bavaria, Bavaria, Germany, on December 25, 2024, a safe and convenient cycle and pedestrian connection exists between Passau's old town and the Ilz town in the northeast.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11861190
12 December 2024
A line of Velo Antwerp rental bicycles stands ready for use at a busy city center location in Antwerp, Belgium, on July 31, 2023. As pedestrians stroll past the station, this sustainable mobility solution offers an eco-friendly and convenient way to navigate the city. The bright red bicycles and the bustling urban backdrop highlight the integration of green transportation options into the daily lives of both residents and visitors.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11409035
15 July 2024
A sign for cylcists and pedestrians is seen on a combined path in Warsaw, Poland on 14 July, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6274256
14 December 2020
Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6274258
14 December 2020
Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6274260
14 December 2020
Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6274262
14 December 2020
Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6274264
14 December 2020
Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6274266
14 December 2020
Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.